Russia's RDIF Sovereign Wealth Fund has applied for Sputnik V to be registered in the European Union and expects it to be checked in February, with the official COVID-19 vaccine promotion account tweeted on Wednesday, taking it closer to wider global acceptance.
In Argentina, Belarus, Serbia and other countries, the vaccine is already approved.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews.
The country would submit a formal application to the European Union in February for approval of its Sputnik V coronavirus vaccine, RDIF chief Kirill Dmitriev had said in an interview at the Reuters Next conference last week.
"Sputnik V and European Medical Agency teams held the Scientific Review of #SputnikV on 19 January. RDIF filed for Sputnik V registration in the EU and expects it to be reviewed in February. Based on these reviews EMA will decide on the authorization of Sputnik V for the EU," the statement read.